Tag: preclinical data

August 21, 2019

Aptinyx Presents Data of NYX-458 in Preclinical Model of Head Injury

Aptinyx (NASDAQ:APTX) has announced presentation of preclinical data on its novel NMDA receptor modulator, NYX-458. As quoted in te press...
June 21, 2019

Catabasis Pharmaceuticals Presents Preclinical Data of Edasalonexent

Catabasis Pharmaceuticals (NASDAQ:CATB) has announced preclinical data for its edasalonexent in Phase 2 development to treat Duchenne musclar dystrophy (DMD)....
May 24, 2018

Medicenna Receives Amendment to Revamp Clinical Trial

The Investing News Network had the opportunity to speak with Medicenna CEO Fahar Merchant at the Bloom Burton & Co....
May 23, 2018

Providing Non-Exclusive Licenses Makes Zymeworks “Lucky,” Says CEO

The Investing News Network spoke with Zymeworks CEO Ali Tehrani at the Bloom Burton & Co. Health Care Conference, which...
May 10, 2018

Aptevo Therapeutics Reports First Quarter 2018 Financial Results

Aptevo Therapeutics (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today provided a business review and...
May 9, 2018

OncoMed Announces First Quarter 2018 Financial Results and Operational Highlights

OncoMed Pharmaceuticals (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today announced first quarter 2018...
May 8, 2018

New Preclinical Data for Novel Immunotherapy Bispecific Candidate ALG.APV-527 Presented by Aptevo Therapeutics and Alligator Bioscience at Prominent Industry Conferences

Aptevo Therapeutics (Nasdaq:APVO), a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics, and Alligator Bioscience (Nasdaq Stockholm:ATORX), a...